Details of the Drug Reposition

General Information of This Drug (ID: DM02MRW)

Drug Name
Remestemcel-L   DM02MRW
Synonyms MSC-100-IV
Drug Type
Cell therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Graft-versus-host disease DIS0QADF 4B24 Phase 3 [1]
Crohn disease DIS2C5Q8 DD70 Phase 3 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02652130) Safety Follow-up of Treatment With Remestemcel-L in Pediatric Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD. U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT01233960) Evaluation of PROCHYMAL for Treatment-refractory Moderate-to-severe Crohn's Disease. U.S. National Institutes of Health.